News
The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals found disputed issues over the sincerity of Jeanette Diaz's ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
Biocon chief Kiran Mazumdar-Shaw has pushed back against Karnataka Chief Minister Siddaramaiah's recent claim that COVID-19 ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results